Drug interactions in cancer patients: A hidden risk?

por Riechelmann, Rachel, Girardi, Daniel
Publicado 2016

Targeting the Hedgehog Pathway in Cancer: Current Evidence and Future Perspectives

por Girardi, Daniel, Barrichello, Adriana, Fernandes, Gustavo, Pereira, Allan
Publicado 2019

Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation

por Fernandes, Gustavo S., Girardi, Daniel M., Bernardes, João Paulo G., Fonseca, Felipe P., Fregnani, Eduardo R.
Publicado 2018

Plasmacytoid urothelial carcinoma: a case of histological variant of urinary bladder cancer with aggressive behavior

por da Fonseca, Leonardo Gomes, Souza, Ciro Eduardo, Mattedi, Romulo Loss, Girardi, Daniel Motta, Sarkis, Álvaro Sadek, Hoff, Paulo Marcelo Gem
Publicado 2014

Systemic Therapy for Advanced Hepatocellular Carcinoma: Current Stand and Perspectives

por Girardi, Daniel M., Sousa, Lara P., Miranda, Thiago A., Haum, Fernanda N. C., Pereira, Gabriel C. B., Pereira, Allan A. L.
Publicado 2023

Impressive response to immunotherapy in a metastatic gastric cancer patient: could somatic copy number alterations help patient selection?

por dos Santos Fernandes, Gustavo, da Motta Girardi, Daniel, Dib Batista Bugiato Faria, Luiza, Giacomini Bernardes, João Paulo, de Almeida Coudry, Renata
Publicado 2017

Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care?

por Fernandes, Gustavo S., Marques, Daniel F., Girardi, Daniel M., Braghiroli, Maria Ignez F., Coudry, Renata A., Meireles, Sibele I., Katz, Artur, Hoff, Paulo M.
Publicado 2017

Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives

por Girardi, Daniel M., Pacífico, Jana Priscila M., Guedes de Amorim, Fernanda P. L., dos Santos Fernandes, Gustavo, Teixeira, Marcela C., Pereira, Allan A. L.
Publicado 2020

Acquired hemophilia A in a patient with advanced prostate cancer

por Girardi, Daniel da Motta, Silva, Douglas Rafael Almeida, Villaça, Paula Ribeiro, Souza, Ciro Eduardo, da Fonseca, Leonardo Gomes, Bastos, Diogo Assed, Hoff, Paulo Marcelo Gehm
Publicado 2015

Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis

por Girardi, Daniel M., de Lima, Mariana A., Pereira, Gabriel C. B., Negrão, Marcelo V., López, Rossana V. M., Capareli, Fernanda C., Sabbaga, Jorge, Hoff, Paulo Marcelo G.
Publicado 2018

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

por Girardi, Daniel M., Niglio, Scot A., Mortazavi, Amir, Nadal, Rosa, Lara, Primo, Pal, Sumanta K., Saraiya, Biren, Cordes, Lisa, Ley, Lisa, Ortiz, Olena Sierra, Cadena, Jacqueline, Diaz, Carlos, Bagheri, Hadi, Redd, Bernadette, Steinberg, Seth M., Costello, Rene, Chan, Keith S., Lee, Min-Jung, Lee, Sunmin, Yu, Yunkai, Gurram, Sandeep, Chalfin, Heather J., Valera, Vladimir, Figg, William D., Merino, Maria, Toubaji, Antoun, Streicher, Howard, Wright, John J., Sharon, Elad, Parnes, Howard L., Ning, Yang-Min, Bottaro, Donald P., Cao, Liang, Trepel, Jane B., Apolo, Andrea B.
Publicado 2022

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

por Apolo, Andrea B., Nadal, Rosa, Girardi, Daniel M., Niglio, Scot A., Ley, Lisa, Cordes, Lisa M., Steinberg, Seth M., Sierra Ortiz, Olena, Cadena, Jacqueline, Diaz, Carlos, Mallek, Marissa, Davarpanah, Nicole N., Costello, Rene, Trepel, Jane B., Lee, Min-Jung, Merino, Maria J., Bagheri, Mohammad Hadi, Monk, Paul, Figg, William D., Gulley, James L., Agarwal, Piyush K., Valera, Vladimir, Chalfin, Heather J., Jones, Jennifer, Streicher, Howard, Wright, John J., Ning, Yangmin M., Parnes, Howard L., Dahut, William L., Bottaro, Donald P., Lara, Primo N., Saraiya, Biren, Pal, Sumanta K., Stein, Mark N., Mortazavi, Amir
Publicado 2020